Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2020 | Story Nonsindiso Qwabe | Photo Supplied
Leah Molatseli is the founder of Lenoma Legal, a legal technology company which specialise in commercial and labour matters for small and medium businesses.

Legal technology and innovation specialist and member of the University of the Free State Council, Leah Molatseli, tackled the intersection of law and technology in her new book, titled #LegalTech Startups and Innovation

As technology continues to revolutionise how traditional industries function, legal tech is no longer a foreign concept in the country’s current legal market. The technological boom that has occurred over the past few decades has reshaped many industries. Molatseli said her book is a bridge in the knowledge gap; it is a comprehensive guide for using new technologies in order to provide legal services that are not restricted by physical barriers. 

Molatseli said in her career as a lawyer, she has witnessed first-hand the need for ordinary citizens to gain greater access to justice.  This has led her to adopt new technology that works for the client by cutting costs, improving efficiency, and reaching people more effectively. In 2017, she co-founded Lenoma Legal, a legal tech start-up that provides legal services virtually. 

“While a digital divide still exists, mobile penetration has increased drastically in the past few years, making it much easier to provide legal help from anywhere. My hope is that this book will open up different avenues for law firms, entrepreneurial people who want to innovate within the legal space, and Law students to start thinking differently about how they can shape their careers.”

Technology pivotal to legal industry

Molatseli said she decided at the beginning of 2020 to put the knowledge she gained into a book. When the COVID-19 pandemic hit South Africa, it quickly became apparent that the legal profession had to seek alternative ways to carry out its functions, and the pivotal role that technology has played made the book a timely release. 

“The pandemic has cemented the need for access from anywhere in the world. For me, it’s about access. I believe that access to legal services is a basic human right, and legal tech and innovation plays a huge role in making that happen,” she said. 

Molatseli said #Legaltech Startups and Innovation is a guide that will equip other forward-thinking practitioners to do exactly the same. She said as technology continued to advance, it is becoming easier for anyone within the legal world to create and build solutions.

Book shines light on new avenues in law

“For many years we’ve been made to think that legal careers are linear; get your degree and go work in a law firm, but it’s no longer like that. There are so many avenues open to people within the law industry, and the moment you become aware of this, you can take charge of your career. If we can integrate this type of thinking, the opportunities are endless. This book can drastically change how we do things and how we approach law.”

The book is available for ordering from: https://juta.co.za/catalogue/legaltech-startups-and-innovation_28319/. If you would like to get more information on the book, follow Leah Molatseli on Twitter at @leahmolatseli. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept